A Structured Intervention for Medical Students Significantly Improves Awareness of Stigmatisation in Visible Chronic Skin Diseases: A Randomised Controlled Trial.
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
31 Jan 2022
31 Jan 2022
Historique:
pubmed:
15
12
2021
medline:
2
2
2022
entrez:
14
12
2021
Statut:
epublish
Résumé
People with visible skin diseases often experience stigmatisation. The aim of this study was to develop and evaluate a new intervention for medical students to counter the stigmatisation of people with skin diseases. The intervention was evaluated using a randomised controlled design. Effectiveness was assessed at 3 time points. Data from 127 participants were analysed. Regarding the outcome "social distance", a significant difference between the measurement points was observed for the intervention group (χ2(2) = 54.32, p < 0.001), which also showed a significant effect on agreement with negative stereotypes (F(1.67, 118.67) = 23.83, p < 0.001, partial η2 = 0.25). Regarding the outcome "agreement with disease-related misconceptions", a significant difference between the measurement time points was observed for the intervention group (χ2(2) = 46.33, p < 0.001); similar results were found for the outcome "stigmatising behaviour" (F(1.86, 131.89) = 6.16, p = 0.003, partial η2 = 0.08). The results should encourage medical faculties to invest in such courses in order to prevent stigmatisation of people with skin diseases.
Identifiants
pubmed: 34904689
doi: 10.2340/actadv.v101.894
pmc: PMC9631292
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00641Références
Br J Dermatol. 2011 Oct;165(4):865-73
pubmed: 21623753
Lepr Rev. 2017 Mar;88(1):2-22
pubmed: 30188085
BMJ Open. 2018 Dec 22;8(12):e024877
pubmed: 30580274
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
J Eur Acad Dermatol Venereol. 2007 Apr;21(4):456-61
pubmed: 17373970
J Health Commun. 1998 Oct-Dec;3(4):327-44
pubmed: 10977261
Epidemiol Psychiatr Sci. 2011 Sep;20(3):263-71
pubmed: 21922969
J Dtsch Dermatol Ges. 2020 Feb;18(2):93-102
pubmed: 32026645
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2846-2855
pubmed: 32277524
J Invest Dermatol. 2015 Apr;135(4):984-991
pubmed: 25521458
Clin Cosmet Investig Dermatol. 2019 Oct 16;12:785-790
pubmed: 31802927
Psychiatr Serv. 2012 Oct;63(10):963-73
pubmed: 23032675
J Dermatol. 2017 Aug;44(8):885-891
pubmed: 28407292
Neuropsychiatr. 2020 Jun;34(2):66-73
pubmed: 32112263
Br J Psychiatry. 2009 Jun;194(6):491-9
pubmed: 19478286
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1493-1504
pubmed: 33428316
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411
pubmed: 31465592
Hautarzt. 2019 Jul;70(7):520-526
pubmed: 31134287
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1822-1827
pubmed: 32003871
Int J Nurs Stud. 2013 May;50(5):587-92
pubmed: 23159157
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2029-2038
pubmed: 31177601
Acad Psychiatry. 2012 May 1;36(3):197-204
pubmed: 22751821
Health Psychol. 2016 Aug;35(8):861-5
pubmed: 27505208
J Am Acad Dermatol. 2019 Jun;80(6):1556-1563
pubmed: 30171876
AIDS Behav. 2021 Sep;25(9):2815-2826
pubmed: 33506305
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Dermatol Ther. 2020 Jul;33(4):e13541
pubmed: 32385861
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004003
pubmed: 26485128
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2202-2208
pubmed: 31087405